
University of Newcastle
Encourages students to think outside the box.
Makes learning exciting and meaningful.
Brings passion and energy to teaching.
A true inspiration to all who learn.
Great Professor!
Professor Fiona Day is a distinguished academic at the University of Newcastle, Australia, with a notable career in medical oncology and cancer research. Her expertise and contributions have made significant impacts in the field of oncology, particularly in breast cancer treatment and clinical trials.
Professor Day holds advanced qualifications in medicine and oncology. While specific details of her degrees and institutions are not fully disclosed in public records, her professional standing and appointments reflect a robust academic foundation in medical sciences.
Professor Day specializes in medical oncology, with a primary focus on breast cancer. Her research interests include improving treatment outcomes through clinical trials, personalized medicine, and the development of innovative therapeutic strategies for cancer patients.
While specific awards and fellowships for Professor Day are not widely documented in public sources, her leadership in oncology research and clinical practice suggests recognition within her field. Further details may be available through institutional records or professional networks.
Professor Day has contributed to numerous peer-reviewed articles and studies, particularly in the domain of breast cancer treatment. Below is a selection of her notable works based on publicly available data:
Professor Day has made substantial contributions to the field of medical oncology through her involvement in clinical trials and patient-centered research. Her work has influenced treatment protocols for breast cancer and other malignancies, enhancing survival rates and quality of life for patients. She is recognized for bridging the gap between research and clinical practice in Australia.
Professor Day is actively involved in the academic and medical community, though specific details of public lectures or editorial roles are limited in public records. She participates in national and international oncology conferences and contributes to committees focused on cancer research and treatment guidelines in Australia.